- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Trajectory of Heart Failure Treatment Strategies
Experts highlight the future of heart failure management.
EP: 1.Identifying Key Risk Factors for Heart Failure
EP: 2.Socioeconomic Factors Impacting Development of Cardiac Disease
EP: 3.Distinguishing Between Heart Failure Classifications
EP: 4.Staging Heart Failure and the Importance of Early Diagnosis
EP: 5.The Role of the Primary Care Physician in Heart Failure Management
EP: 6.Four Pillars of Heart Failure Therapy
EP: 7.Selecting Optimal First-line Therapy for Patients Diagnosed with Heart Failure
EP: 8.Key Takeaways From Heart Failure Clinical Trials
EP: 9.Navigating the Patient Journey Through Heart Failure Diagnosis
EP: 10.Strategies for Treating Preserved Ejection Fraction (HFpEF)
EP: 11.Treatment Optimization Challenges Associated With Heart Failure
EP: 12.Financial Barriers Impeding Optimal Heart Failure Treatment
EP: 13.Trajectory of Heart Failure Treatment Strategies
EP: 14.Key Takeaways from Experts in Heart Failure Management
This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD.
When asked about the future of heart failure management, Desai says he is excited about better phenotyping beyond ejection fraction to personalize care. Groves notes this complexity reinforces the need for collaborative, integrative care models. Albert looks forward to disruptive innovations such as devices putting control in patients’ hands, such as glucose monitors for diabetes. Axsom envisions remote monitoring technology empowering self-management. Wright would like research on biomarkers predicting heart failure progression rates to guide treatment intensity. Groves stresses addressing social determinants such as nutrition that influence life outside healthcare visits. Asking where patients shop for food provides insights. In summary, the future of heart failure care involves better phenotyping, disruptive technologies, remote monitoring, risk stratification tools, and addressing social needs, all aimed at optimizing outcomes through individualized, patient-centered care.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Gene Therapy Enhances Visual Processing for Inherited Retinal Disease
December 3rd 2024Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.
Read More
New Guidelines Clarify EORTC Quality of Life Scores for Chronic Lymphocytic Leukemia
December 2nd 2024Meaningful change thresholds for the EORTC Quality of Life Questionnaire in chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are: −11/+11 for symptom burden, −16/+16 for physical condition/fatigue, and −16/+13 for worries/fears.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS
November 29th 2024The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated with disability worsening despite not relapsing—known as progression independent of relapse activity.
Read More
